 |
Doug Macron is the editor of GenomeWeb's Gene Silencing News. He covers research and therapeutic applications of RNAi, miRNA, and other gene-silencing technologies. E-mail Doug Macron or follow his GenomeWeb Twitter account at @Genesilencing. |
Benitec Reveals Delays in its Pipeline Programs as Corporate Revitalization Continues
June 21, 2012
Benitec Reveals Delays in its Pipeline Programs as Corporate Revitalization Continues
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Benitec Provides Pipeline Update Following Tacere Acquisition
October 18, 2012 / Gene Silencing News - Benitec Aims for Three Clinical Programs, Industry Partnership in 2013
April 5, 2012 / Gene Silencing News - Benitec Raises Funds for HCV Trial through Private Placement
March 7, 2013 / Gene Silencing News - Benitec Looks to Outlicense IP While Avoiding Litigation Mistakes of Its Past
November 8, 2012 / Gene Silencing News - With Drugs in the Clinic, Gradalis Starts Looking to Partner Its Technologies
October 11, 2012 / Gene Silencing News